Biomanufacturing in the Industry 4.0 Era: Balancing Innovation with Performance While Not Being Disrupted
Posted on January 26, 2021
Christos Varsakelis, Senior Manager Global Data Analytics & Innovation,
GlaxoSmithKline Biologicals SA
Abstract Current manufacturing operations constitute a compromise between innovation and performance. Ten years after the formal commencement of the Industry 4.0 era, discussions about moving to a new paradigm are intensifying. Biomanufacturing has only but recently started examining the opportuniti...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















